Cite

HARVARD Citation

    Zhang, L. et al. (2022). STAT3 is a biologically relevant therapeutic target in H3K27M-mutant diffuse midline glioma. Neuro-oncology. 24 (10), pp. 1700-1711. [Online]. 
  
Back to record